Ted Liberti
State College, Pennsylvania, United States
Ted Liberti is a prominent figure in the biotechnology industry, known for his role in BioMagnetic Solutions and the development of the revolutionary X-GRAFFE™ cell selection system for CAR-T cell and gene therapy product manufacture.
His expertise in immunomagnetic platforms and cell selection technologies has led to the creation of innovative solutions for CGT applications.
With a rich educational background including degrees from prestigious institutions like the University of Delaware, University of Oxford, and Penn State University, Ted Liberti has a strong foundation in economics, business, and technology management.
As the co-founder and former CEO of BioMagnetic Solutions, Ted has demonstrated exceptional leadership and entrepreneurial skills in bringing cutting-edge technologies to the market.
His professional journey includes diverse roles in organizations such as AquaMagnetic Solutions Corporation, Liberti Pincus Limited, and Immunicon Corp., where he honed his expertise in business development, strategy, and product innovation.
Ted Liberti's contributions extend beyond the biotech industry, with involvement in academia, wine industry coordination, banking consultancy, and sports apprenticeship, showcasing his versatile skill set and interests.
With a focus on innovation, problem-solving, and continuous learning, Ted Liberti embodies a strong ethos of preparation, tenacity, and team collaboration to drive impactful change in the field of biotechnology.
His commitment to excellence is evident in BioMagnetic Solutions' proprietary nanomagnetic liquids and magnetic cell selection devices, positioning the company as a leader in addressing complex challenges in CGT applications.
